ICD-10 Coding for Pituitary Macroadenoma(C75.1, C75.1U, C75.9M)
Comprehensive guide on ICD-10 coding for pituitary macroadenoma, including primary and secondary codes, documentation requirements, and common pitfalls.
Complete code families applicable to Pituitary Macroadenoma
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D35.2 | Benign neoplasm of pituitary gland | For non-functional macroadenomas >1 cm without hormone excess. |
|
| E22.1 | Hyperprolactinemia | For prolactin-secreting macroadenomas. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutPituitary Macroadenoma
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Pituitary Macroadenoma.
Omitting tumor size in documentation.
Impact
Clinical: Inaccurate clinical assessment., Regulatory: Non-compliance with documentation standards., Financial: Potential claim denials.
Mitigation
Standardize MRI reporting templates., Educate clinicians on documentation standards.
Coding D35.2 without specifying tumor size.
Impact
Reimbursement: Potential denial due to lack of specificity., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.
Mitigation
Always document and code tumor size >1 cm.
Tumor Size Documentation
Impact
Lack of tumor size documentation leads to coding errors.
Mitigation
Implement mandatory fields in EHR for tumor size.